Meeting
2020 Genitourinary Cancers Symposium
mTOR pathway alterations in chromophobe renal cell carcinoma: Impact on metastasis development and overall survival.
Authors
Pablo Maroto
Department of Medical Oncology, Hospital de Sant Pau, Barcelona, Spain
Pablo Maroto , Georgia Anguera , Jose Maria Roldan , E. Caleiras , M. Santos , Jesús García-Donas , Guillermo de Velasco , J. Lanillos , AM Martínez , B. Calsina , R. Leton , Lj Leandro-Garcia , M. Monteagudo , Cristina Montero-Conde , Alberto Cascon , Mercedes Robledo , Cristina Rodríguez-Antona
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 712)
Abstract #
712
Poster Bd #
H10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Malignant epithelioid angiomyolipoma (eAML)/PEComa of the kidney: A genomic landscape study.
First Author: Rebecca A Sager
Poster
2014 ASCO Annual Meeting
Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway as prognostic factors for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial tumors.
First Author: Joaquim Bellmunt
Poster
2022 ASCO Annual Meeting
Age as a factor in the molecular landscape and the tumor-microenvironmental signature of osteosarcoma.
First Author: Andreas Seeber
Poster
2014 Genitourinary Cancers Symposium
Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway and prognostic significance for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial cancer (UC).
First Author: Joaquim Bellmunt